Osimertinib as first-line treatment of EGFR mutant advanced non-small-cell lung cancer

被引：13

作者：

Liam, Chong-Kin ^{[1
]}

机构：

[1] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia

来源：

TRANSLATIONAL LUNG CANCER RESEARCH | 2017年 / 6卷

关键词：

SINGLE-ARM; AZD9291; MULTICENTER; RESISTANCE; MUTATIONS; ERLOTINIB; TKI;

D O I：

10.21037/tlcr.2017.10.10

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S62 / S66

页数：5

共 18 条

[1] The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial [J].

Costa, Carlota ;

Molina, Miguel Angel ;

Drozdowskyj, Ana ;

Gimenez-Capitan, Ana ;

Bertran-Alamillo, Jordi ;

Karachaliou, Niki ;

Gervais, Radj ;

Massuti, Bartomeu ;

Wei, Jia ;

Moran, Teresa ;

Majem, Margarita ;

Felip, Enriqueta ;

Carcereny, Enric ;

Garcia-Campelo, Rosario ;

Viteri, Santiago ;

Taron, Miquel ;

Ono, Mayumi ;

Giannikopoulos, Petros ;

Bivona, Trever ;

Rosell, Rafael .

CLINICAL CANCER RESEARCH, 2014, 20 (07) :2001-2010

[2] AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer [J].

Cross, Darren A. E. ;

Ashton, Susan E. ;

Ghiorghiu, Serban ;

Eberlein, Cath ;

Nebhan, Caroline A. ;

Spitzler, Paula J. ;

Orme, Jonathon P. ;

Finlay, M. Raymond V. ;

Ward, Richard A. ;

Mellor, Martine J. ;

Hughes, Gareth ;

Rahi, Amar ;

Jacobs, Vivien N. ;

Brewer, Monica Red ;

Ichihara, Eiki ;

Sun, Jing ;

Jin, Hailing ;

Ballard, Peter ;

Al-Kadhimi, Katherine ;

Rowlinson, Rachel ;

Klinowska, Teresa ;

Richmond, Graham H. P. ;

Cantarini, Mireille ;

Kim, Dong-Wan ;

Ranson, Malcolm R. ;

Pao, William .

CANCER DISCOVERY, 2014, 4 (09) :1046-1061

[3]

Eberlein C, 2014, P AACR ANN M 2014 AP

[4] Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study [J].

Goss, Glenwood ;

Tsai, Chun-Ming ;

Shepherd, Frances A. ;

Bazhenova, Lyudmila ;

Lee, Jong Seok ;

Chang, Gee-Chen ;

Crino, Lucio ;

Satouchi, Miyako ;

Chu, Quincy ;

Hida, Toyoaki ;

Han, Ji-Youn ;

Juan, Oscar ;

Dunphy, Frank ;

Nishio, Makoto ;

Kang, Jin-Hyoung ;

Majem, Margarita ;

Mann, Helen ;

Cantarini, Mireille ;

Ghiorghiu, Serban ;

Mitsudomi, Tetsuya .

LANCET ONCOLOGY, 2016, 17 (12) :1643-1652

[5] AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer [J].

Jaenne, Pasi A. ;

Yang, James Chih-Hsin ;

Kim, Dong-Wan ;

Planchard, David ;

Ohe, Yuichiro ;

Ramalingam, Suresh S. ;

Ahn, Myung-Ju ;

Kim, Sang-We ;

Su, Wu-Chou ;

Horn, Leora ;

Haggstrom, Daniel ;

Felip, Enriqueta ;

Kim, Joo-Hang ;

Frewer, Paul ;

Cantarini, Mireille ;

Brown, Kathryn H. ;

Dickinson, Paul A. ;

Ghiorghiu, Serban ;

Ranson, Malcolm .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18) :1689-1699

[6] Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer [J].

Mok, T. S. ;

Wu, Y. -L. ;

Ahn, M. -J. ;

Garassino, M. C. ;

Kim, H. R. ;

Ramalingam, S. S. ;

Shepherd, F. A. ;

He, Y. ;

Akamatsu, H. ;

Theelen, W. S. M. E. ;

Lee, C. K. ;

Sebastian, M. ;

Templeton, A. ;

Mann, H. ;

Marotti, M. ;

Ghiorghiu, S. ;

Papadimitrakopoulou, V. A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) :629-640

[7]

*NAT COMPR CANC NE, NCCN CLIN PRACT GUID

[8] Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Novello, S. ;

Barlesi, F. ;

Califano, R. ;

Cufer, T. ;

Ekman, S. ;

Levra, M. Giaj ;

Kerr, K. ;

Popat, S. ;

Reck, M. ;

Senan, S. ;

Simo, G. V. ;

Vansteenkiste, J. ;

Peters, S. .

ANNALS OF ONCOLOGY, 2016, 27 :v1-v27

[9] Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer [J].

Oxnard, Geoffrey R. ;

Thress, Kenneth S. ;

Alden, Ryan S. ;

Lawrance, Rachael ;

Paweletz, Cloud P. ;

Cantarini, Mireille ;

Yang, James Chih-Hsin ;

Barrett, J. Carl ;

Janne, Pasi A. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) :3375-+

[10] Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation [J].

Oxnard, Geoffrey R. ;

Arcila, Maria E. ;

Sima, Camelia S. ;

Riely, Gregory J. ;

Chmielecki, Juliann ;

Kris, Mark G. ;

Pao, William ;

Ladanyi, Marc ;

Miller, Vincent A. .

CLINICAL CANCER RESEARCH, 2011, 17 (06) :1616-1622

← 1 2 →